Allelic losses demonstrate monoclonality of multifocal bladder tumors

International Journal of Cancer

Volumn 87, Issue 4, 2000, Pages 522-527

  Louhelainen, J ^a   Wijkstrm, H ^b   Hemminki, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CHROMOSOME MAP; CLINICAL ARTICLE; HETEROZYGOSITY LOSS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0033889228     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000815)87:4<522::AID-IJC10>3.0.CO;2-X     Document Type: Article

References (35)

1. Multiple head and neck tumors: Evidence for a common clonal origin
2. Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?
3. p53 expression compared with other prognostic factors in OMS graded-I stage-Ta transitional cell carcinoma of the bladder
4. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology
5. Genetic alterations in bladder cancer
6. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer
7. Frequent association of p53 gene mutation in invasive bladder cancer
8. p53 mutations in multiple urothelial carcinomas: A molecular analysis of the development of multiple carcinomas
9. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression
10. Metachronous multifocal development of urothelial cancers by intraluminal seeding
11. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer
12. Bladder cancer - Field versus clonal origin
13. Loss of heterozygosity and microsatellite instability in larynx cancer
14. Dinucleotide repeat polymorphism within the tumor suppressor gene PTCH at 9q22
15. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and URINARY BLADDER
16. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine
17. Analyzes of p53 gene mutations in primary human bladder cancer
18. Role of chromosome 9 in human bladder cancer
19. Antisense RNA-mediated reduction of p53 induces malignant phenotype in nontumorigenic rat urothelial cells
20. Tobacco smoke, recurrences, and p53/bcl-2 expression in bladder cancer
21. p53 mutations in phenacetin-associated human urothelial carcinomas
22. Imprinting the genome: Imprinted genes, imprinting genes, and a hypothesis for their interaction
23. Principles and practice of oncology
24. Partial allelotype of carcinoma in situ of the human bladder
25. Genetics of bladder cancer
26. Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers - Investigation by temperature gradient gel electrophoresis (TGGE)
27. Synchronous oral carcinomas: Independent or common clonal origin?
28. Identification of p53 gene mutations in bladder cancers and urine samples
29. Clonal origin bladder cancer
30. Two molecular pathways to transitional cell carcinoma of the bladder
31. Multifocal transitional cell cancer and p53 mutation analysis
32. Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences
33. Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers
34. Clonal analysis of urothelial carcinomas in C3H/HeN mutually implies BALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine
35. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines